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Experimental design optimization approach was utilized to develop a sequential injection analysis (SIA) method for promazine
assay in bulk and pharmaceutical formulations. The method was based on the oxidation of promazine by Ce(IV) in sulfuric acidic
media resulting in a spectrophotometrically detectable species at 512nm. A 33 full factorial design and response surface methods
were applied to optimize experimental conditions potentially controlling the analysis. The optimum conditions obtained were
1.0 × 10
−4 M sulphuric acid, 0.01M Ce(IV), and 10μL/s ﬂow rate. Good analytical parameters were obtained including range
of linearity 1–150μg/mL, linearity with correlation coeﬃcient 0.9997, accuracy with mean recovery 98.2%, repeatability with
RSD 1.4% (n = 7 consequent injections), intermediate precision with RSD 2.1% (n = 5 runs over a week), limits of detection
0.34μg/mL, limits of quantiﬁcation 0.93μg/mL, and sampling frequency 23 samples/h. The obtained results were realized by the
British Pharmacopoeia method and comparable results were obtained. The provided SIA method enjoys the advantages of the
technique with respect to rapidity, reagent/sample saving, and safety in solution handling and to the environment.
Copyright © 2007 Abubakr M. Idris et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Experimental conditions including chemical and instrumen-
tal eﬀect dependently and/or independently on the eﬃciency
of analytical methods in diﬀerent levels. Therefore, the opti-
mization of these conditions potentially develops analytical
methods. Despite its limitation, the univariate method has
still been applied for the optimization of analytical methods.
This may be due to its simplicity and familiarity. The uni-
variate method optimizes conditions one-by-one by varying
levels of one condition while keeping others constant at un-
speciﬁed levels.
Experimental design, including factorial design and re-
sponse surface, is a multivariate approach recommended for
the development of analytical methods. This approach is ap-
plied to (a) reduce large amount of data that could be eas-
ily interpreted, (b) examine main and interaction eﬀects of
experimental conditions on the eﬃciency of methods, and
(c)optimizesimultaneouslyexperimentalconditionsregard-
ing their interaction with each other by a minimum num-
ber of experiments [1]. Furthermore, the response surface
methodisapowerfultoolforruggednesstesting[1].Rugged-
ness evaluates the eﬃciency of analytical methods under the
variation of experimental conditions [2].
In1990,sequentialinjectionanalysis(SIA)techniquewas
introduced as the second generation following ﬂow injec-
tion analysis (FIA) technique with dramatic modiﬁcations
anddevelopments[3].TheversatilityofSIAenablesthetech-
nique to hyphen with diﬀerent types of detection including
spectrophotometry, ﬂuorescence, chemiluminescence, elec-
trochemical, mass spectrometry, and so forth. In addition,
as SIA is a fully automated technique, more accurate, pre-
cise and safer analytical methods could be adopted; rather
than safety in solution handling and reduction of man-
power in analytical laboratories. Furthermore, the minia-
turization of the technique drastically reduces volumes of
reagents/samples from the scale of milliliters to microliters.
This does not only oﬀer reagent/sample saving but also of-
fers rapidity and safety to the environment. Due to these ad-
vantages, SIA has been extensively applied to pharmaceutical
analysis [4, 5].
Promazine is chemically known as 3-(10H-phenothia-
zin-10-yl)-N, N-dimethylpropan-1-amine hydrochloride
(Figure 2). It is a phenothiazine neuroleptic agent with
strong anticholinergic, hypotensive, and sedative eﬀects and2 Journal of Automated Methods and Management in Chemistry
moderate antiemetic eﬀects. Promazine is additionally used
as an adjunct agent in the management of severe pain [6–8].
The increasing use of promazine in medicine has
prompted the development of several methods for its quan-
titative determination in bulk form and pharmaceutical
preparations. For this purpose, a wide variety of analytical
techniques were utilized including titrimetry [9, 10], spec-
trophotometry [7, 8, 11], chemiluminescence [12, 13], elec-
trophoresis [14, 15], conductimetry [16], polarography [17],
and FIA [18, 19].
In general, most of the previous spectrophotometric
methods for phenothiazines assay are unsatisfactory for dif-
ferent reasons, for example, some of them lacked sensitiv-
ity or speciﬁcity [20–23]. Some others required long time of
heating or lengthy procedure or were conducted in nonaque-
ous media [24]. Moreover, these methods are not straight-
forward since they did not base on the detection of one of
promazine derivatives.
In the present study, SIA technique was utilized to adopt
a new method for the assay of promazine hydrochloride
in bulk and pharmaceutical preparations. The method was
based on the oxidation of promazine by Ce(IV) in sulphuric
acid media resulting in a spectrophotometrically detectable
species. Experimental conditions potentially controlling the
method including Ce(IV) concentration, sulfuric acid con-
centration, and ﬂow rate were optimized using experimental
design-based methods.
2. EXPERIMENTAL
2.1. Chemicalsandreagents
All chemicals and reagents used in this study were of analyti-
calreagentgrade;andthequalityofwaterwasdistilleddeion-
ized. Promazine hydrochloride was supplied from Sigma
(Taufkirchen, Germany). Ammonium cerium sulphate di-
hydrate (Ce(NH4)4(SO4)4 ·2H2O), hydrochloric acid, sul-
phuricacid,andsodiumhydroxideweresuppliedfromFluka
(Buchs, Switzerland). Promazine hydrochloride in bulk form
aswellasinactiveingredientspossiblyfoundinpharmaceuti-
cal formulations were a generous gift from Samf (Khartoum
North, Sudan). These ingredients included sodium citrate,
citric acid, sodium formaldehyde sulphoxylate, microcrys-
talline cellulose, magnesium stearate, maize starch, titanium
dioxide, carnauba wax, propylene glycol, povidone, and talc.
2.2. Instrumentationandsoftwarepackages
The manifold used in this method is composed of sequen-
tial injection analyzer combined with miniaturized ﬁber op-
tic spectrometer. Full components of the manifold are dia-
grammed in Figure 1.
SIA manifold used in this study is a FIALab 3500 (Med-
ina, WAUSA).Itis composed of a syringe pump (SP),multi-
position valve (MPV), holding coil (HC), and Z-ﬂow cell (Z)
as well as pump tubing and personal computer (PC). The
SP includes 24,000 increments with high-resolution stepper
motor, which drives the piston at rates from 1.5seconds to
10.0min per stroke. It is >99% accuracy at full stroke. The
syringe has a volume of 2.5mL. The MPV is chemically in-
ert and has eight ports with a standard pressure of 250psi
(gas)/600psi (liquid); zero dead volume. The Z is 10mm
path-length Plexiglass compatible with ﬁber optic connec-
tors. Pump tubing of “0.03 inch” ID Teﬂon type supplied
from Upchurch Scientiﬁc, Inc. (Oak Harbor, WA, USA) was
used to connect SIA units and to make HC with a long of
200cm.
The optical devices were composed of radiation source,
spectrometer, and ﬁber optic connectors. They were fabri-
cated by Ocean Optics (Dunedin Florida, USA). The radia-
tion source is an LS-1 Tungsten Halogen lamb optimized for
VIS-NIR (360nm–2μm wavelength range). The detector is a
USB2000 Spectrometer adapted to 200–1100nm wavelength
range. The ﬁber optic connectors are 200 micron Sub Minia-
ture version A (SMA).
FIALab for Windows version 5.0 supplied from FIAlab
(Medina, WA, USA) was used for programming and con-
trolling SIA manifold. SigmaPlot for Windows version 9.01
supplied from Systat Software, Inc. (Point Richmond, CA,
USA) was used for data interpolation and constructing sur-
face plots.
2.3. Preparationofstandardsolutionsandsamples
A3.516×10−3 Mpromazinehydrochloride(1000μg/mLpro-
mazine) as a primary standard solution was prepared in
aqueous media and stored protected from light. A 0.10M
Ce(IV) as a primary standard solution was prepared in
0.01M sulphuric acid media. Secondary standard solutions
of promazine, Ce(IV), and sulphuric acid were prepared by
dilution in the appropriate way.
Promazine is taken by patients in injection or tablets for-
mulations[7,8].Theseformulationswiththeappropriatein-
activeingredientswerepreparedatourlaboratory.Ampoules
were synthesized by mixing 50mg of promazine hydrochlo-
ride with other inactive ingredients including sodium cit-
rate, citric acid, and sodium formaldehyde sulphoxylate in
a total quantity of 5mg. Tablets were synthesized by mixing
50mg of promazine hydrochloride and excipients including
microcrystalline cellulose, magnesium stearate, maize starch,
titanium dioxide, carnauba wax, propylene glycol, povidone,
and talc in a total quantity of 10mg. Ingredients of both in-
jection and tablets formulations were dissolved in water to
give a ﬁnal volume of 10mL. Placebo injection and tablets
samples were prepared by mixing the appropriate excipients.
All solutions were ﬁltered and the ﬁltrates were used for fur-
ther analysis.
2.4. SIAprocedure
A suitable SIA manifold was constructed. As shown in
Figure 1, water was linked to the inposition in the SP and
to port-1 in the MPV. Sulphuric acid, Ce(IV), and placebo
sample were linked to port 2, 3, and 4, respectively. Stan-
dards/sampleswerelinkedtoport5to7.Zwaslinkedtoport
8.AnappropriateprotocolcontrollingtheSIAprocedurewasAbubakr M. Idris et al. 3
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Figure 1: Schematic diagram of a SIA manifold constructed for promazine assay.
programmed using FiaLab software. It is brieﬂy described as
follows.
( i )A taﬂ o wr a t eo f1 5 0μL/s, the syringe was ﬁlled with
1000μLo fw a t e r .
(ii) Tubes were loaded by aspirating 100μLo fe a c ho fs u l -
phuric acid, Ce(IV), placebo, and standards/samples,
and then the syringe was emptied.
(iii) 30μL of each of sulphuric acid, Ce(IV), and blank so-
lutions and 10μL of water as a spacer solution were
sequentially aspirated into the HC. The solutions were
mixed by short reverse strokes.
(iv) At the required ﬂow rate, a volume of 1000μL was dis-
pensedtotheZ;andthereferenceandabsorbancescan
were carried out at wavelength 512nm.
(v) To measure the absorbance of promazine derivative,
steps (iii) and (iv) were repeated with replacing stan-
dard/sample solutions instead of placebo solution.
(vi) Values of peak height of absorbance of both placebo
and standards/samples were recorded. The diﬀerence
was calculated and the obtained values are termed as
“response” in the following sections.
3. RESULTS AND DISCUSSION
3.1. Preliminaryinvestigation
A preliminary investigation on a possible oxidation of pro-
mazine indicated that promazine is oxidized by the means of
Ce(IV) in sulphuric acid media at room temperature in a fast
reaction. The scheme of the reaction is depicted in Figure 2.
Similar to what has been earlier proposed to another mem-
ber of phenothiazines [25], promazine is oxidized to form
mono- and dication radicals in two steps. The free radical
recorded maximum absorbance at 512nm, and no spectrum
interference was recorded from other species in the matrix of
the adopted reaction.
3.2. Experimentaldesignoptimization
Beforeundertakinganyoptimizationstudy,itisimportantto
delineate clearly the boundaries of conditions controlling the
analysis, namely, sulphuric acid concentration, Ce(IV) con-
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Figure 2: Proposed reaction scheme of promazine oxidation by
Ce(IV) in sulphuric acid media.
centration, and ﬂow rate. Preliminary investigation revealed
that acid concentration bellow 1.0 × 10−4 M, hydrolysis of
C e ( I V ) ,t o o kp l a c e .A c i dc o n c e n t r a t i o na b o v e0 . 1 0M ,d e n s e
yellow color, was produced in the mixture of Ce(IV) and the
acid. This caused spectrum interference with the analyte. On
the other hand, high acid concentration decreased the re-
peatability of SIA measurement. For Ce(IV) concentration,
0.01M was considered at the maximum since beyond this
level the solution is not stable. Below 1.0×10−4 M, the molar
equivalency of Ce(IV) would not be enough to oxidize rela-
tively high concentration of promazine in bulk and pharma-
ceutical formulations. A ﬂow rate ranging from 10 to 60μL/s
was found to be suitable for spectrophotometric measure-
ment.
When applying experimental design methodologies, it is
advisable to keep the number of variables as low as possible
in order to avoid very complex response models and large
variability [1].
3.3. Themainandinteractioneffectfactors
A3 3 full factorial design was carried out; where the base 3
standsforvariablelevelsconsideringthelowest,themedium,
and the highest values; and the power 3 is the number of4 Journal of Automated Methods and Management in Chemistry
parameters that would be optimized. The ranges obtained
from the preliminary investigation were considered as mini-
mum and maximum levels, while medium levels were math-
ematically calculated. 27 experiments, as the result of the
adopted factorial design, were conducted and the results ob-
tained are introduced in Table 1.
The main and interaction eﬀect factors were calculated
and the results obtained are depicted in Figure 3. For the
main factors, the level of the positive eﬀe c to fC e ( I V )c o n -
centration was higher than the level of the negative eﬀect of
ﬂow rate; and the latter was higher than the level of the neg-
ative eﬀect of acid concentration. For the interaction eﬀect
factors, the level of the negative interaction eﬀect of Ce(IV)
concentration with ﬂow rate was higher than other levels of
interaction eﬀect factors. The eﬀect factor study concluded
that Ce(IV) and ﬂow rate were found to be critically con-
trolling the adopted method. The negative interaction eﬀect
of Ce(IV) concentration with acid concentration may be at-
tributed to the increase of the potential oxidation of Ce(IV)
concentration with the decrease of acid concentration. On
the other hand, higher acid concentration negatively eﬀects
the stability of the oxidized form of promazine leading to its
disassociation.Asproposedbefore,althoughtheoxidationof
promazine is fast, the negative eﬀect of ﬂow rate may be due
to phenomena that low ﬂow rate delays solution in tubings,
and thus dispersion is increased. This enhanced the reaction,
and thus the absorbance of the detectable species increased.
3.4. Responsesurface
The coded levels of the adopted factorial design with their
respective responses were interpolated; and the response sur-
face plots were constructed. As examples, two ﬁgures are de-
picted. Figure 4 shows the response surface plot as a func-
tion of Ce(IV) concentration versus acid concentration. The
highest response obtained was above 0.50. The general trend
of the ﬁgure is that the eﬀe c to fC e ( I V )c o n c e n t r a t i o ni s
higher than the eﬀect of acid concentration. The bimodal
shape appearing at the left side indicates that acid concen-
tration interacts with higher Ce(IV) concentrations. The re-
sponse of the surface plot of acid concentration versus ﬂow
rate reaches 0.75. The ﬂow rate resembled a higher eﬀect on
the response value than that of acid concentration. Figure 5
shows the response surface plot as a function of Ce(IV) con-
centration versus ﬂow rate. As shown in this ﬁgure, the high-
est response obtained was above 1.0 when Ce(IV) concen-
tration was at the highest level and the ﬂow rate was at the
lowest. Therefore, it was decided to consider 0.01M Ce(IV)
and ﬂow arte 10μL/s as the optimum. On the other hand,
based on its negative eﬀect on the response, 1.0×10−4 Mw a s
considered as the optimum acid concentration.
3.5. Methodvalidation
A long series of standard solutions of promazine were sub-
jected to the optimized SIA method for the purpose of cal-
ibration. Beer’s law was found to be obeyed in the concen-
tration range of 1–150μg/mL with weighed regression “R =
0.0082C +0 .0956,” where R is the response, C is the concen-
Table 1: A 33 factorial design matrix with experimental results (re-
sponses).
Experiment number Factor Response
A1 C2 F3
1 −1 −1 −1 0.149
2 −1 −10 0.116
3 −1 −1+ 1 0.081
4 −10 −1 0.267
5 −100 0.117
6 −10 + 1 0.103
7 −1+ 1−1 2.013
8 −1+ 1 0 0.669
9 −1+ 1+ 1 0.641
10 0 −1 −1 0.237
11 0 −10 0.204
12 0 −1+ 1 0.12
13 00 −1 0.165
14 000 0.104
15 00 + 1 0.108
16 0+ 1−1 1.100
17 0+ 1 0 0.273
18 0+ 1+ 1 0.173
19 +1 −1 −1 0.257
20 +1 −10 0.187
21 +1 −1+ 1 0.114
22 +1 0 −1 0.251
23 +1 0 0 0.100
24 +1 0 +1 0.090
25 +1 +1 −1 1.334
26 +1 +1 0 0.321
27 +1 +1 +1 0.203
(1) Sulphuric acid concentration (M); (2) Ce(IV) concentration (M);
(3) ﬂow rate (μL/s).
Table 2: Results obtained by the SIA and BP methods for pro-
mazine assay in pharmaceutical formulations.
Sample type Mean recovery ± RSD1
t-test value
SIA method BP method
Bulk 99.4 ± 0.9 99.1 ± 1.2 1.4
Injection 98.1 ± 1.7 98.6 ± 2.2 1.7
Tablets 97.8 ± 1.6 102.7 ± 2.4 2.1
(1) Relative standard deviation for 10 consequent injections.
tration of promazine in μg/mL. The correlation coeﬃcient
was 0.9997 indicating good linearity. Figure 6 shows a typi-
cal SIA calibration obtained under the optimum conditions
by triplicate consequent injection of four standard solutions
of promazine (1, 50, 100, and 150μg/mL).
The accuracy was examined by analyzing bulk, tablets,
and injection formulations. The obtained results were real-
ized by the British Pharmacopoeia (BP) method. BP pro-
vided a classical potentiometric titration method by sodium
hydroxide for promazine assay in bulk form [7]; and aAbubakr M. Idris et al. 5
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Figure 3: ThemainandinteractioneﬀectfactorsofCe(IV)concentration(M),acidconcentration(M),andﬂowrate(μL/s)ontheresponse
of the proposed SIA method.
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Figure 4:ResponsesurfaceplotofCe(IV)concentration(M)versus
sulphuric acid concentration (M).
classical spectrophotometric method in hydrochloric acid
media in tablets and injection formulations. Analysis for
each sample was repeated seven times, and the relative
standard deviation (RSD) was calculated. The t-test values
were also calculated. The results obtained are introduced in
Table 2.TheobtainedresultsindicatingthattheprovidedSIA
method is accurate and repeatable.
The intermediate precision of the SIA method was exam-
ined by analyzing the same solutions 5 times over a week.
Relative standard deviation (RSD) of the mean recovery for
samples under study was 2.1% indicating good intermediate
precision.
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Figure 5:ResponsesurfaceplotofCe(IV)concentration(M)versus
ﬂow rate (μL/s).
The limits of detection (LOD) and quantiﬁcation (LOQ)
were also examined. LOD was calculated as 3.3(s/S) and
LOQ as 10(s/S) where s is the standard deviation for seven
replicates of the measurement of placebo solution, S is slope
of the weighed regression of calibration equation. The LOD
and LOQ obtained were 0.34 and 0.93μg/mL, respectively,
indicating good detectability.
4. CONCLUSIONS
The SIA technique was utilized to adopt a simple, accu-
rate, precise, rapid, and reagent/sample saving method for6 Journal of Automated Methods and Management in Chemistry
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Figure 6: A typical SIA calibration obtained by triplicate injection
of four standard solutions of promazine (1,50,100, and 150μg/mL)
under the optimum conditions 30μLo f1 .0 × 10−4 M sulphuric
acid, 30μLo f0 . 0 1MC e ( I V ) ,3 0μL of promazine, 10μLw a t e r ,a n d
10μL/s ﬂow rate.
the assay of promazine in bulk and pharmaceutical formula-
tions.Unlikepreviousspectrophotometricmethods,thecur-
rentmethodhastheadvantageofthestraightforwardnessfor
monitoringtheactualradicalspeciesformoftheanalyte.The
factorial design and response surface methods were success-
fullyappliedtooptimizeexperimentalconditionscontrolling
the method. This oﬀers a wide range of linearity and good
detectability. The merits of automation and miniaturization
of the utilized technique rendered the proposed method to
have advantages over the BP method with respect to repeata-
bility, rapidity, reagent/sample saving, and safety in solution
handling and to the environment.
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